These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 25973047)
1. ClC-3 chloride channel modulates the proliferation and migration of osteosarcoma cells via AKT/GSK3β signaling pathway. Du S; Yang L Int J Clin Exp Pathol; 2015; 8(2):1622-30. PubMed ID: 25973047 [TBL] [Abstract][Full Text] [Related]
2. Silence of ClC-3 chloride channel inhibits cell proliferation and the cell cycle via G/S phase arrest in rat basilar arterial smooth muscle cells. Tang YB; Liu YJ; Zhou JG; Wang GL; Qiu QY; Guan YY Cell Prolif; 2008 Oct; 41(5):775-85. PubMed ID: 18823498 [TBL] [Abstract][Full Text] [Related]
3. Requirement of ClC-3 in G0/G1 to S Phase Transition Induced by IGF-1 via ERK1/2-Cyclins Cascade in Multiple Myeloma Cells. Du Y; Tu YS; Tang YB; Huang YY; Zhou FM; Tian T; Li XY Clin Lab; 2018 Jun; 64(6):929-936. PubMed ID: 29945325 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway. Shang Y; Wang LQ; Guo QY; Shi TL Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752 [TBL] [Abstract][Full Text] [Related]
5. Matrine inhibits the growth and induces apoptosis of osteosarcoma cells in vitro by inactivating the Akt pathway. Xu GP; Zhao W; Zhuang JP; Zu JN; Wang DY; Han F; Zhang ZP; Yan JL Tumour Biol; 2015 Mar; 36(3):1653-9. PubMed ID: 25371071 [TBL] [Abstract][Full Text] [Related]
6. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway. Li YJ; Dong BK; Fan M; Jiang WX Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584 [TBL] [Abstract][Full Text] [Related]
8. SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling. Liu X; Zhou X; Xu H; He Z; Shi X; Wu S DNA Cell Biol; 2017 Sep; 36(9):775-780. PubMed ID: 28777670 [TBL] [Abstract][Full Text] [Related]
9. EZH2 promotes the progression of osteosarcoma through the activation of the AKT/GSK3β pathway. Wan D; Han X; Zhang C; Zhang Y; Ma Y; Wang G Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1179-1186. PubMed ID: 35818168 [TBL] [Abstract][Full Text] [Related]
10. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells. Du JY; Wang LF; Wang Q; Yu LD Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572 [TBL] [Abstract][Full Text] [Related]
11. c-Src regulates cell cycle proteins expression through protein kinase B/glycogen synthase kinase 3 beta and extracellular signal-regulated kinases 1/2 pathways in MCF-7 cells. Liu X; Du L; Feng R Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):586-92. PubMed ID: 23615537 [TBL] [Abstract][Full Text] [Related]
12. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro. Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625 [TBL] [Abstract][Full Text] [Related]
13. The CLC-2 Chloride Channel Modulates ECM Synthesis, Differentiation, and Migration of Human Conjunctival Fibroblasts via the PI3K/Akt Signaling Pathway. Sun L; Dong Y; Zhao J; Yin Y; Zheng Y Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294913 [TBL] [Abstract][Full Text] [Related]
14. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro. Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways. Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640 [TBL] [Abstract][Full Text] [Related]
16. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway. Ong CS; Zhou J; Ong CN; Shen HM Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656 [TBL] [Abstract][Full Text] [Related]
17. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration. Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500 [TBL] [Abstract][Full Text] [Related]
18. URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway. Liu Y; Xi Y; Chen G; Wu X; He M J Orthop Surg Res; 2020 Jun; 15(1):226. PubMed ID: 32552851 [TBL] [Abstract][Full Text] [Related]
19. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor. Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022 [TBL] [Abstract][Full Text] [Related]
20. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells. Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]